Clinical trials
Children, Only clinical trials
Below are recruiting children, only clinical trials, each written for real people, not researchers. We’re tracking 3,109 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06302933Recruiting
Negative HIV test in children treated early: a study
This study looks at why some HIV-positive children who started treatment early may have a negative HIV antibody test. It uses stored blood samples from children who were in the Pediacam III study to better understand the immune response.
DoualaAges Any age - NCT06302985Recruiting
Inhaled dye for lung malformations in children
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
Wuhan, HubeiAges 3 months–14 years - NCT06304194Recruiting
Collecting blood and tumor samples for cancer research
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
FlorenceAges birth–30 years - NCT06305611Recruiting
Studying Kawasaki disease in Europe and North India
This study looks at children with Kawasaki disease, a condition that causes inflammation in blood vessels. The goal is to learn more about how it affects kids in Europe and North India.
Rio de JaneiroAges 1–17 - NCT06305663Recruiting
Contact lens to slow myopia in children
This study tests a special contact lens designed to slow the progression of nearsightedness (myopia) in children ages 8 to 12. If your child is nearsighted and needs glasses, this lens might help reduce the need for stronger prescriptions over time.
Beijing, Beijing MunicipalityAges 8–12 - NCT06305910RecruitingPhase 1
Vaccine immunotherapy for recurrent brain tumors or newly diagnosed DIPG
This trial tests a combination of a vaccine made from tumor cells and a drug that may boost the immune system's ability to fight brain tumors. It is for children and young adults with a recurrent high-grade glioma or a newly diagnosed diffuse midline glioma with a specific genetic marker (H3K27M).
Minneapolis, MinnesotaAges 2–25 - NCT06306196RecruitingPhase 2
Hepatitis E vaccine study in healthy adults, children, and people with HIV
This study tests a hepatitis E vaccine called Hecolin in healthy people (ages 2–45) and in adults (18–45) living with HIV who are on antiviral treatment. It aims to see how well the vaccine works and if it's safe for different groups.
Ga-RankuwaAges 2–45 - NCT06310109Recruiting
PICU Diaries to Support Children and Families
This study tests whether a special diary, kept by families during the PICU stay, helps children and their parents cope better after leaving the hospital. It is for children who needed a breathing machine for more than 48 hours.
RomeAges Up to 19 years - NCT06311110Recruiting
Toilet training and bladder issues in children with DCD
This study looks at how Developmental Coordination Disorder (DCD) affects toilet training, bladder, and bowel function in children. It compares children with DCD to those with typical development to identify differences and problems.
Ghent, East FlandersAges 5–8 - NCT06311682RecruitingPhase 3
Testing a new shot plus steroid cream for children with eczema
This study tests an investigational shot (tralokinumab) plus a steroid cream for children with moderate-to-severe eczema that hasn't been controlled by creams alone. It aims to see if the combination is safe and works better than the cream alone.
Birmingham, AlabamaAges 6 months–11 years - NCT06315179Recruiting
Spatial gene study for inflammatory bowel disease
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
Seattle, WashingtonAges 6–21 - NCT06316960RecruitingPhase 2
Avapritinib for children with relapsed or resistant CBF-AML and KIT mutation
This trial tests a targeted drug called avapritinib in children and teens with a specific type of leukemia (CBF-AML) that has a KIT gene change and has come back or not responded to treatment. The goal is to see if avapritinib is safe and effective for these patients.
Hefei, AnhuiAges Up to 18 years - NCT06319430Recruiting
Play study for kids with physical disabilities
This study looks at how children with physical disabilities play using technology. It may help understand their play patterns and needs.
Winnipeg, ManitobaAges 3–9 - NCT06320106Recruiting
Navigating abilities in children with cerebral palsy
This study compares how children with cerebral palsy and their peers navigate spaces. It aims to understand differences in orientation and movement skills.
Bosisio Parini, LeccoAges 13 years+ - NCT06322264Recruiting
Helping children take part in X-ray exams
This study tests a new method to help children aged 4 to 12 feel more involved and comfortable during standard X-rays. It may make the experience easier for kids, parents, and radiographers.
Lund, Skåne CountyAges 4–12 - NCT06324136Recruiting
Personalized diagnosis for rare kidney diseases
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
FlorenceAges birth–70 years - NCT06324539Recruiting
New method to detect celiac disease markers during endoscopy
This trial tests a new way to find specific markers for celiac disease during a routine endoscopy. It may help people who are getting an endoscopy to check for celiac or other digestive conditions.
NaplesAges 2–17 - NCT06324955Recruiting
Using words during mask anesthesia in children
This study looks at whether simple spoken words during the process of falling asleep with a breathing mask can help children ages 5–10 have a better experience. The goal is to make anesthesia induction less scary for kids.
Boston, MassachusettsAges 5–10 - NCT06325098Recruiting
Personalized diagnosis for nephrotic syndrome
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
FlorenceAges 1 month–40 years - NCT06325059Recruiting
Kidney cell study for glomerular and tubular diseases
This trial studies kidney biopsy samples to learn how certain kidney cells repair damage. It may help find new treatments for kidney diseases.
FlorenceAges 1 month–17 years - NCT06325293Recruiting
Macrolide vs. placebo for mycoplasma pneumonia in children
This trial tests whether azithromycin (a macrolide antibiotic) is better than a placebo for treating mycoplasma pneumonia in children aged 3–17. If your child has pneumonia caused by mycoplasma, this study may help find the best treatment.
Aarau, Canton of AargauAges 3–17 - NCT06325280Recruiting
Exercise MRI for Kids with Heart Conditions
This study uses an MRI while exercising to check heart and lung fitness in children with heart disease. It helps doctors learn more about how to care for kids who have had a heart transplant or were born with heart problems.
Edmonton, AlbertaAges 10–18 - NCT06325813Recruiting
TMS therapy for ADHD in teens
This study tests if a type of brain stimulation called TMS can help teenagers with ADHD control their impulses better. The treatment targets a part of the brain that helps with stopping or changing actions.
Cincinnati, OhioAges 12–17 - NCT06455384Recruiting
Studying a digital tool for genetic testing services
This trial tests a new online tool called the Genetics Navigator, which helps people access genetic testing services more easily. If you or your child have been referred for genetic testing at Mount Sinai Hospital or SickKids in Toronto, this study may help you manage the process online.
Toronto, OntarioAges 18 years+
Hear when a new Children, Only trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for children, only?
- Yes. Clin2 currently lists 3,109 recruiting children, only studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a children, only trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a children, only trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.